Global Transfection Technologies Market Forecast Report to 2028 - Increasing R&D Efforts in Cell Biology, Growing Focus on Personalized Medicines and Rising Demand for Advanced Therapeutic Products

DUBLIN, March 21, 2024 /PRNewswire/ -- The "Global Transfection Technologies Market by Product (Kits, Equipment), Method (Physical (Electroporation, Microinjection), Biochemical (Lipofection, Calcium Phosphate), Viral), Application (Biomedical Research, Therapeutic Delivery) - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

The transfection technologies market is projected to reach USD 1.8 billion by 2028 from an estimated USD 1.2 billion in 2023, at a CAGR of 9.4% during the forecast period.

The growth of this market can be attributed to the technological advancements in physical transfection methods, increasing research and development efforts in cell biology, growing focus on personalized medicines, and rising demand for advanced therapeutic products.

The kits & reagents segment accounted for the largest share by product type in 2022

In 2022, the kits & reagents segment accounted for the largest share of product type in the global transfection technologies market. The factors like growing demand for high quality reagents to transfect nucleic acids into cells. The increasing focus on development of personalized medicines is also driving the growth of this market. Furthermore, the market share of the kits & reagents market is expected to grow simultaneously with the increasing need for advanced therapies.

The North America dominated the transfection technologies market during the forecast period of 2023-2028

North America dominated the global transfection technologies market in 2022. This dominance is attributed to the presence of academic and research centers, often associated with drug discovery and development. Additionally, the region is experiencing increased investments in biologics and advanced dosage forms. The growing need to expedite the drug development process, which typically spans 10 to 12 years, has further fueled the demand for transfection technologies. Consequently, the North America market is witnessing growth due to the development of novel drug products and the growing research and development in cell biology efforts in the region.

Key Topics Covered:

Executive Summary

• Transfection Technologies Market, by Product, 2023 vs. 2028 (USD Million)
• Transfection Technologies Market, by Method, 2023 vs. 2028 (USD Million)
• Transfection Technologies Market, by Application, 2023 vs. 2028 (USD Million)
• Transfection Technologies Market, by End-user, 2023 vs. 2028 (USD Million)
• Transfection Technologies Market: Geographic Analysis

Premium Insights

• Transfection Technologies Market Overview - Growing Demand for Cell and Gene Therapy to Drive Market Growth
• Asia-Pacific: Transfection Technologies Market, by Product and Country - Kits & Reagents Held Largest Share of Asia-Pacific Market in 2022
• Transfection Technologies Market: Geographic Growth Opportunities - India to Register Highest CAGR in Global Transfection Technologies Market Over Forecast Period
• Transfection Technologies Market Share, by Product, 2022 - Kits & Reagents Held Largest Share of Products Market in 2022

Market Dynamics

Drivers

• Increasing Demand for Cell and Gene Therapy
• Rising Research Activity and R&D Funding
• Alliances for Developing Advanced Therapeutic Products
• Expanded Applications of Transfection Technologies
• Technological Advancements

Restraints

• Limited Efficiency of Transfection Methods
• High Cost of Transfection Products
• Adoption of Alternative Methods

Opportunities

• Rising Focus on Personalized Medicines
• Growth Opportunities in Emerging Economies

Challenges

• Concern Related to Cytotoxicity and Transfection in Hard-To-Transfect Cells
• Challenges Associated with Large-Scale Transfection Processes

Companies Profiled:

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Qiagen
• Merck KGaA
• Sartorius AG (Polyplus)
• Lonza
• F. Hoffmann-La Roche Ltd.
• Agilent Technologies, Inc.
• Maxcyte
• Revvity
• Takara Bio Inc.
• Promega Corporation
• Danaher Corporation
• Boc Sciences
• Rjh Biosciences
• Synvolux
• Altogen Biosystems
• Bioivt
• Incella GmbH
• Invivogen
• Phoreus Biotech
• Stemcell Technologies
• Ez Biosystems
• Oz Biosciences
• Chemicell GmbH

For more information about this report visit https://www.researchandmarkets.com/r/abtdop

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets